Maven Clinic’s most important enrollment distinction is not between one medication and another. It is between paying for care and paying for the prescription that may follow. Its consumer GLP-1 membership starts at $39 for the first month, but medication is billed separately by the pharmacy. The lower advertised membership rates also require a different payment arrangement: prepayment rather than ordinary monthly billing. Understanding those separate transactions matters before treating any headline amount as the cost of starting or continuing treatment.
This review examines Maven’s public documentation consulted October 19, 2026, with a focus on enrollment obligations, service boundaries and financial exit questions. Maven describes virtual metabolic and hormone-focused care for women, including assessment, prescribing when appropriate and ongoing support. Those offerings are documented, but the consulted material does not establish complete cancellation rules, prepaid-refund rights or state-by-state availability. The practical question is therefore what a prospective member can confirm now—and what needs a written answer before payment.
At a glance
- Membership and medication are separate
- Maven advertises $39 for the first membership month and $150 per month afterward on monthly billing. Pharmacy medication charges are additional.Sources: [8]
- Lower rates require prepayment
- Alternatives are $297 every three months, $534 every six months or $888 every 12 months, advertised as monthly equivalents of $99, $89 and $74.Sources: [8]
- Included care has boundaries
- First nutrition and strength consultations are included; unlimited visits are limited to the initial GLP-1 care team, whose composition is left incomplete in a pricing footnote.
- Refund eligibility is conditional
- Maven says someone whose clinician determines GLP-1 treatment is unsuitable may qualify for a refund. Complete payment terms were not available in the consulted text.Sources: [8]
- Location affects access
- Maven states that services and prescribing vary by location, availability and applicable law; the documentation does not identify a confirmed GLP-1 service territory.Sources: [8]
Start by identifying which Maven service you are buying
Maven’s homepage identifies GLP-1 Care as a Maven Consumer, self-pay service. It advertises access to brand-name prescriptions, on-demand visits with metabolic and hormone health specialists, and nutrition and strength support. That is distinct from the employer- or health-plan-covered family benefits also promoted on its website. For example, Maven describes maternity and newborn care as free for covered members. That statement does not establish free GLP-1 membership or medication for someone who already has another Maven benefit.
There is also a separate employer-facing pricing model: Maven says it charges a fixed cost per enrolled member, potentially varying with company size. Neither that arrangement nor the platform’s claim of coverage and services across more than 175 countries establishes the terms of this consumer purchase. Before enrolling, identify the program name, payer and benefit being offered. The broader enrollment terms checklist is useful here because the Maven brand spans materially different purchasing arrangements.
Read the membership price as a billing schedule
The dedicated pricing page states $39 for the first month and $150 per month afterward. It also says, “Pay monthly, or prepay for a lower rate. Your first month is always $39.” Monthly billing is therefore an available choice, not a requirement to purchase an annual package. Conversely, the $74 headline rate is not an offer to pay $74 each month: it represents an annual option billed at $888 every 12 months. None of these membership amounts includes medication.
The three-month option is advertised at $99 per month, collected as $297 every three months; the six-month option is $89 per month, collected as $534 every six months. Those payment intervals matter more than the monthly equivalents when assessing how much money is committed at a transaction. Maven does not explain in the consulted material exactly how the introductory $39 month aligns with the start or billing dates of prepaid plans. Obtain that schedule before authorizing the charge.
The page’s recurring billing language provides useful information, but it does not supply complete renewal and termination rules. A three-, six- or 12-month billing interval does not establish medication quantity, treatment duration or all contractual obligations. The distinction between a monthly price and a billing commitment is especially relevant to Maven’s prepaid options. Ask for the first charge, the next charge date and amount, and the rule governing any later renewal—not merely the advertised monthly equivalent.
| Option | Advertised membership price | Collection and clarification |
|---|---|---|
| Monthly | $39 first month; $150 per month afterward | Monthly option; confirm the next billing date |
| Three months | $99 monthly equivalent | $297 every three months; confirm introductory-month alignment |
| Six months | $89 monthly equivalent | $534 every six months; confirm introductory-month alignment |
| 12 months | $74 monthly equivalent | $888 every 12 months; confirm introductory-month alignment |
The pharmacy bill has its own conditions
Maven says its membership covers the visits and care needed to obtain and continue a GLP-1 prescription; the pharmacy bills for medication according to drug and dose. Its table advertises Wegovy pills from $149 per month self-pay and Wegovy autoinjector pens from $199. Foundayo pills start at $149. For each, the insured column says prices start as low as $25 per month. These are conditional advertised minimums, not individualized quotes or proof that a particular insurance plan will pay.
Zepbound KwikPen is listed from $299 per month self-pay and as low as $25 with insurance. A separate Zepbound listing is headed “Vial” but also labeled “Autoinjector pen,” with the same advertised minimums. That internal inconsistency should be resolved before ordering. Ozempic pens are advertised from $199 self-pay and as low as $25 with insurance; the detailed $199 offer is for the 0.25 mg presentation as a new-patient introduction through December 31, 2026, then $349 per month.
Maven also says some medications must be refilled within 45 days of the previous order to retain the best available manufacturer pricing. This is a commercial refill condition, not a delivery promise or an instruction to change treatment. Its insurance advocates offer benefits assistance before starting, but the membership itself is not insurance-covered. A useful written quote would identify the exact product, presentation, applicable promotion, pharmacy price and coverage assumptions, rather than combining membership and medication into one apparently predictable monthly figure.
Enrollment buys an evaluation, not a guaranteed prescription
Maven’s initial assessment asks about hormonal history, life stage and conditions such as PCOS or perimenopause. The company says a licensed clinician reviews it before the first visit. Its eligibility explanation refers to BMI, medical history and existing conditions, with possible requests for laboratory testing or prior records depending on history and location. The consulted documentation does not publish a minimum age or specific BMI eligibility thresholds. It therefore does not support deciding personal eligibility from the marketing page alone.
If GLP-1 treatment is not appropriate, Maven says it can help develop another plan based on goals and health history, potentially involving hormones or other options. That is a description of possible care, not an automatic substitute purchase or a promise of any particular prescription. Before paying, clarify whether additional testing has a separate charge, whether an alternative plan remains within the purchased membership and what financial outcome follows a clinician’s decision not to prescribe GLP-1 medication.
Unlimited support has a narrower contractual boundary
Maven describes ongoing messaging, the ability to schedule video calls and tracking of symptoms and progress that the care team can see. Its materials also mention side-effect management and personalized weight and metabolic insights. These are useful descriptions of the support model, but “anytime” access to messaging or scheduling should not be read as a guaranteed immediate clinical response. The consulted pages do not establish response-time standards, appointment turnaround or a detailed escalation pathway for treatment concerns.
The pricing footnote limits unlimited visits to the initial GLP-1 Care Team, then leaves that team’s membership as “[xxx].” It further says additional visits or services may cost extra. Elsewhere, Maven includes the first nutrition and strength consultations but says additional visits can be booked, while access to its full provider network is described as pay-as-you-go. Ask for named included professional roles, repeat-visit allowances and additional-visit prices. Broad access to a network is not equivalent to unlimited included appointments throughout that network.
Separate the clinician’s work from pharmacy fulfillment
Maven says prescriptions are sent to the patient’s pharmacy, with direct-to-home shipping available for select medications. It does not identify the dispensing pharmacies in the consulted material or provide preparation, dispatch or arrival timelines. Shipping charges and cold-chain arrangements are also not established. A prospective member should confirm which pharmacy receives the prescription, who collects payment and who handles an unavailable product or delivery problem. A completed clinical visit does not itself establish that a pharmacy order is ready or has shipped.
The company says it prescribes only FDA-approved GLP-1 products, naming semaglutide as Wegovy and Ozempic, tirzepatide as Zepbound, and orforglipron as Foundayo; it says it does not offer compounded formulations. Maven also states that these medications may be prescribed off-label based on clinical judgment and carry risks, including serious side effects. FDA approval of a product does not mean every prescribed use is FDA-approved. Those are Maven’s product representations, not independent verification of dispensing or FDA approval of the clinic itself. For injectable deliveries, FDA explicitly advises not using a GLP-1 product that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. Responsibility for resolving that problem should be clear before shipment.
Cancellation and refunds remain the largest documentation gap
Maven says that if a clinician determines GLP-1 medication is not a fit, the member “may qualify for a refund,” directing readers to Payment Terms & Conditions. That wording is conditional. The complete linked terms were not available in the consulted text, so this review cannot establish qualifying circumstances, covered charges, submission deadlines or processing timelines. Nor can it confirm whether a prepaid balance is refundable after care begins. The distinction between refund eligibility and a refund guarantee is central to this purchase.
The documentation also does not establish the complete automatic-renewal rules, required cancellation method or advance-notice deadline. It would be inappropriate to infer that stopping membership returns a prepaid balance or cancels a pharmacy transaction already underway. Ask for the cancellation route, effective date and treatment of pending charges in writing. A separate check of cancellation notice and renewal dates can help organize those questions, but only Maven’s applicable agreement can establish the actual obligations for this enrollment.
Confirm location and keep Hormone Care separate
Maven states that services and prescribing vary with location, availability and applicable law. The consulted pages do not name the states or countries where this consumer GLP-1 program is available, and the coexistence of enrollment and waitlist buttons does not confirm immediate access. Before choosing a billing plan, verify access in the location where care will occur. The materials also do not establish Spanish-language support, individual clinician licensing details or the clinical contracting entity, leaving further practical questions for enrollment.
Hormone Care Essentials is a different offer: a $150 one-time payment, no subscription, two 20-minute consultations and up to 20 messages, with additional visits and medication charged separately. Its fee is not insurance-covered, although prescribed medication may be covered and is sent to the preferred pharmacy. Maven lists hormonal and nonhormonal options for that service and says clinicians can direct patients toward testing or in-person care when needed. Those terms should not be imported into GLP-1 membership merely because both programs address hormone-related concerns.
Questions & answers
Does Maven’s $39 first month include GLP-1 medication?
No. The $39 amount is an introductory membership charge. Maven says medication is billed separately by the pharmacy according to the drug and dose. On the monthly membership option, the advertised subsequent charge is $150 per month. Ask for separate membership and pharmacy amounts, plus any testing or additional-visit charges, before treating a quoted figure as the total cost.
Can I pay $74 each month instead of prepaying?
The documented $74 rate is a monthly equivalent for the option billed at $888 every 12 months. It is not presented as a $74 monthly installment plan. Maven separately offers monthly billing at $150 after the introductory month. Its statement that the first month is always $39 leaves the exact alignment with prepaid billing unclear, so request the actual transaction schedule.
Will Maven refund me if I cannot receive a GLP-1 prescription?
Maven says you may qualify for a refund if its clinician determines GLP-1 treatment is unsuitable. That is not an automatic refund promise. The consulted text does not establish the complete eligibility rules, which charges would be returned or when money would be received. Obtain the applicable Payment Terms & Conditions before paying, particularly if considering a prepaid membership.
Are nutrition appointments and every Maven specialist included?
The first nutrition and strength consultations are included, but Maven describes its full provider network as pay-as-you-go. The unlimited-visit footnote applies only to the initial GLP-1 care team and leaves the team description incomplete. Additional services may incur charges. Ask specifically whether a repeat nutrition appointment, strength consultation or specialist visit falls inside your membership and what it costs if not.
Will my existing Maven benefit or insurance pay for this program?
Do not assume so. Maven identifies consumer GLP-1 Care as self-pay and says its membership fee is not covered by insurance. Medication coverage is a separate question; insurance advocates can help investigate benefits before starting. The company’s employer-covered family programs do not establish coverage for this purchase, and advertised medication prices as low as $25 require qualifying coverage rather than merely having an insurance card.
Does Maven guarantee home delivery or immediate enrollment?
No such guarantee is established in the consulted documentation. Maven says prescriptions go to your pharmacy or, for select medications, ship directly to you. It does not publish confirmed delivery timelines here. Services and prescribing also depend on location and availability. Confirm whether you can enroll rather than join a waitlist, which fulfillment route applies and who will resolve pharmacy or shipment problems.
Our assessment
Maven documents a substantive consumer GLP-1 offering rather than simply a prescription checkout: it describes clinician review, hormone-aware assessment, ongoing messaging and video access, plus initial nutrition and strength consultations. Its pricing also makes the separation between membership and medication reasonably visible. The weaker area is the agreement governing that relationship. Complete cancellation provisions, prepaid-refund rules, the precise initial care-team composition and the alignment of introductory and prepaid billing are not established in the consulted material. For a prospective member, the most useful next step is a written confirmation of location eligibility, included services, pharmacy costs, renewal dates and exit terms before choosing a payment interval. Maven’s documented offering merits consideration on those specific terms, but lower monthly equivalents and broad support language should not substitute for knowing what is collected, what remains separately payable and what happens if care cannot proceed.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Maven Clinic — hormone care/pricing ↗
- Maven Clinic — glp 1 care ↗
- Maven Clinic — glp 1 care/how it works ↗
- Maven Clinic — pricing ↗
- Maven Clinic — official website ↗
- Maven Clinic — hormone care/faq ↗
- Maven Clinic — glp 1 care/pricing ↗
- Maven Clinic — glp 1 care/faq ↗